m6A-centered Crosstalk Information
Mechanism of Crosstalk between m6A Modification and Epigenetic Regulation
| Crosstalk ID |
M6ACROT05521
|
[1] | |||
m6A modification
FOXD2-AS1
FOXD2-AS1
METTL3
Methylation
: m6A sites
Direct
Enhancement
Non-coding RNA
FOXD2-AS1
CDKN1A
lncRNA miRNA circRNA
|
|||||
| m6A Modification: | |||||
|---|---|---|---|---|---|
| m6A Regulator | Methyltransferase-like 3 (METTL3) | WRITER | |||
| m6A Target | FOXD2 adjacent opposite strand RNA 1 (FOXD2-AS1) | ||||
| Epigenetic Regulation that have Cross-talk with This m6A Modification: | |||||
| Epigenetic Regulation Type | Non-coding RNA (ncRNA) | ||||
| Epigenetic Regulator | FOXD2 adjacent opposite strand RNA 1 (FOXD2-AS1) | LncRNA | View Details | ||
| Regulated Target | Cyclin-dependent kinase inhibitor 1 (CDKN1A) | View Details | |||
| Crosstalk Relationship | m6A → ncRNA | Enhancement | |||
| Crosstalk Mechanism | m6A regulators directly modulate the functionality of ncRNAs through specific targeting ncRNA | ||||
| Crosstalk Summary | METTL3/FOXD2 adjacent opposite strand RNA 1 (FOXD2-AS1) accelerates cervical cancer progression via a m6A-dependent modality, which serves as a potential therapeutic target for cervical cancer. FOXD2-AS1 recruited lysine-specific demethylase 1 (LSD1) to the promoter region of Cyclin-dependent kinase inhibitor 1 (CDKN1A) to silence its transcription abundance. | ||||
| Responsed Disease | Cervical cancer | ICD-11: 2C77 | |||
| Cell Process | Cell migration | ||||
| Cell proliferation | |||||
In-vitro Model |
Ca Ski | Cervical squamous cell carcinoma | Homo sapiens | CVCL_1100 | |
| HT-3 | Cervical carcinoma | Homo sapiens | CVCL_1293 | ||
| SiHa | Cervical squamous cell carcinoma | Homo sapiens | CVCL_0032 | ||
| C-33 A | Cervical squamous cell carcinoma | Homo sapiens | CVCL_1094 | ||
| HaCaT | Normal | Homo sapiens | CVCL_0038 | ||
| In-vivo Model | A total 5 × 106 stably transfected SiHa cells were subcutaneously injected into the flank of nude mice. | ||||
: m6A sites